Validation of an Allergic Rhinitis Control Test in Teenagers (ARCTado)
Status
Conditions
Treatments
Details and patient eligibility
About
Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in adolescents or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitsis (ARCT) in patients from 12 years of age. However, this study included only 67 adolescents aged 12 to 17 years old and lacked power.
In this new study,the investigators propose, following exactly the same procedure as the pilot study of 2008, to confirme the validation of unmodified Adult questionnaire in adolescents 12 to 17 years inclusive.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients aged 12 to 17 years old, consulting a practitioner for an allergic rhinitis
- parents formulated their study participation agreement by signing the consent form.
Exclusion criteria
- Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatement.
Trial design
Primary purpose
Allocation
Interventional model
Masking
200 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Pascal Demoly, Professor; Anca Chiriac, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal